Health Care: Drugs

Teva Pharmaceutical Industries Ltd (TEVA: NYSE)

$58.96 -0.04 | -0.07%
01/27/15 - 10:12 AM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 1.25B 1.91B 2.77B 3.34B
Operating Gains/Losses 18.00M -3.00M -207.00M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 85.00M 936.00M 704.00M -362.00M
(Increase) Decrease in Inventories 399.00M -449.00M -410.00M -16.00M
(Increase) Decrease In Other Current Assets 106.00M -54.00M -240.00M 51.00M
(Decrease) Increase In Payables 378.00M -19.00M 543.00M -295.00M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 369.00M
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 736.00M 1.23B 407.00M 272.00M
Net Cash From Continuing Operations 3.24B 4.57B 4.13B 4.14B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 3.24B 4.57B 4.13B 4.14B
Sale of Property, Plant & Equipment 187.00M 264.00M 279.00M 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.03B -1.10B -1.05B -710.00M
Acquisitions -39.00M 0.00 -6.56B -4.95B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -104.00M -93.00M -49.00M 29.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.15B -1.13B -7.60B -5.46B
Issuance of Debt 338.00M 1.24B 6.72B 4.04B
Cash Used for Financing Activities
Issuance of Capital Stock 91.00M 14.00M 71.00M 180.00M
Repayment of Long-Term Debt -3.13B -2.21B -1.56B -2.85B
Repurchase of Capital Stock -497.00M -1.16B -899.00M -99.00M
Payment of Cash Dividends -1.09B -855.00M -800.00M -668.00M
Other Financing Charges, Net 407.00M 1.30B -194.00M -30.00M
Net Cash From Financing Activities -3.88B -1.68B 3.34B 573.00M
Effect of Exchange Rate Changes -48.00M 23.00M -21.00M -1.00M
Net Change in Cash & Cash Equivalents -1.84B 1.78B -152.00M -747.00M

Portfolios with TEVA

Latest TEVA Headlines from TheStreet

More Financial News for TEVA

Press Releases for TEVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter